Actively Recruiting
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-10-31
60
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
CONDITIONS
Official Title
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients assigned female at birth
- Booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates
You will not qualify if you...
- Allergy to ketorolac or non-steroidal anti-inflammatory medications
- Allergy to lidocaine
- Presence of thrombocytopenia
- Contraindications to lidocaine
- History of gastritis or gastric ulcer
- Acute renal failure or chronic renal disease
- Chronic liver disease
- History of bleeding diathesis
- Long term narcotic use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
K
Kathleen E Ackert, DO
CONTACT
V
Virginia H Flatow, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here